| Ticker | DXCM |
|---|---|
| ISIN | US2521311074 |
| Sector | Tecnología |
| Industria | Medical - Devices |
| Mercado | NASDAQ |
| Capitalización | $22,889,984,996 |
| Beta | 1,56 |
| Sitio web | https://www.dexcom.com |
| CEO | Jacob Steven Leach |
| Fecha de IPO | 14/04/2005 |
| País | US |
| Dirección | 6340 Sequence Drive, San Diego, CA, 92121 |
| Volumen | 4.914.871 |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital ...
Dexcom Inc opera en el sector Healthcare, industria Medical - Devices.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones